Strict adherence to oncology pathways could potentially send clinicians in the wrong direction, a new statement from the American Society for Clinical Oncology’s (ASCO) Task Force on Clinical Pathways suggested (J Oncol Pract 2016 Jan 12. [Epub ahead of print]).

“When appropriately designed and implemented, oncology pathways are